Is a Remote CGM/Pump Monitoring Program Worth the Cost? Here’s the Real ROI

Why practices are turning to SweetSpot to scale diabetes care without financial risk. 

The Perceived Cost Barrier 

For many endocrinology and primary care practices, the idea of launching a remote monitoring program for continuous glucose monitors (CGMs) and insulin pumps sounds complicated  — and expensive. Staff already feel stretched. Adding new workflows, reviewing more patient data, and keeping up with billing requirements can feel overwhelming. There’s also the question of ROI: Will this program actually benefit the practice financially, or will it just become another time-consuming initiative that eats into limited resources? 

These concerns are valid — but they’re also outdated. Thanks to advancements in remote care infrastructure and billing models, CGM and insulin pump monitoring is no longer a luxury for large systems. It’s a scalable revenue opportunity that fits seamlessly into smaller private endocrinology practices too. 

What if a CGM/insulin pump monitoring program could not only pay for itself — but actually generate significant new revenue without hiring additional staff or taking on financial risk? 

That’s where SweetSpot comes in. 

The SweetSpot Model: Built to Scale, Without the Spend 

SweetSpot acts as an extension of your care team, helping you manage CGM and pump data at scale — enrolling patients, reviewing their data, handling device issues, and following up when trends show concern. 

Unlike traditional models, you don’t need to hire new staff or invest in new infrastructure. We do the heavy lifting. Our certified diabetes care and education specialists (CDCES) work behind the scenes to monitor data, engage patients, and ensure everything is billed appropriately. 

What’s the Financial Upside? 

When practices use SweetSpot, they earn up to $1,000 per patient per year through Remote Patient Monitoring (RPM) billing. That’s revenue tied to: 

• Regular data reviews 

• Documented patient communication 

• Proactive follow-up based on device trends 

Because SweetSpot handles much of the operational burden, this income comes without added overhead costs. 

No Financial Risk. Just Shared Success. 

SweetSpot’s model is designed to be low-risk and high-reward. There are no upfront costs, and we only collect a portion of the new revenue we help you generate. If your practice doesn’t earn, neither do we. That alignment means we’re motivated to help your program succeed. 

The Bottom Line 

Launching a CGM/pump monitoring program doesn’t have to strain your team or your budget. With SweetSpot, practices can scale remote monitoring, improve patient outcomes, and unlock significant revenue — without taking on new hires or financial risk. 

Ready to see the numbers for your practice? Reach out to us at info@sweetspot.health to learn how SweetSpot can help you build a sustainable, profitable CGM/pump monitoring program. 

---

SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care.

SweetSpot combines a centralized software platform for managing diabetes device data, such as data from CGMs and insulin pumps, with wrap-around clinical support services. SweetSpot’s virtual team of Certified Diabetes Care and Education Specialists (CDCES) perform monthly CGM data reviews and coordinate with providers and patients to facilitate treatment plan changes. By actively managing and remotely reviewing CGM data between patient visits, we ensure patients receive timely treatment adjustments to improve glycemic control and patient outcomes.

Additionally, SweetSpot’s automated capture of reimbursable care events optimizes CPT code utilization, unlocking new revenue streams for practices and making our partnerships both clinically effective and financially profitable.